Prognostic Stage IV Breast Cancer AJCC v8 Recruiting Phase 2 / 3 Trials for Famotidine (DB00927)

IndicationStatusPhase
DBCOND0109667 (Prognostic Stage IV Breast Cancer AJCC v8)Recruiting2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04862585Safely Stopping Pre-medications in Patients With Breast Cancer Who Are Receiving PaclitaxelSupportive Care